We are live on ! Find out more

Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
TAK icon
1
Takeda Pharmaceutical
TAK
$69.1B
$69.1B $21.64 0.23%
TEVA icon
2
Teva Pharmaceutical Industries
TEVA
$49B
$49B $41.98 1.39%
HLN icon
3
Haleon
HLN
$40.1B
$40.1B $9.13 0.76%
ZTS icon
4
Zoetis
ZTS
$34.4B
$34.4B $84.73 0.4%
UTHR icon
5
United Therapeutics
UTHR
$24.8B
$24.8B $582.64 0.89%
VTRS icon
6
Viatris
VTRS
$23.6B
$23.6B $20.59 0.72%
NBIX icon
7
Neurocrine Biosciences
NBIX
$16.6B
$16.6B $164.10 0.73%
ELAN icon
8
Elanco Animal Health
ELAN
$13.1B
$13.1B $26.15 0.98%
RDY icon
9
Dr. Reddy's Laboratories
RDY
$12.4B
$12.4B $14.89 1.29%
ALKS icon
10
Alkermes
ALKS
$7.68B
$7.68B $45.73 1.72%
KNSA icon
11
Kiniksa Pharmaceuticals
KNSA
$7.43B
$7.43B $94.55 0.34%
AMRX icon
12
Amneal Pharmaceuticals
AMRX
$7.26B
$7.26B $20.83 1.88%
LNTH icon
13
Lantheus
LNTH
$6.65B
$6.65B $101.71 0.01%
SUPN icon
14
Supernus
SUPN
$6.09B
$6.09B $29.32 1.7%
LQDA icon
15
Liquidia
LQDA
$5B
$5B $55.52 1.51%
HIMS icon
16
Hims & Hers Health
HIMS
$4.16B
$4.16B $17.75 4.36%
AMLX icon
17
Amylyx Pharmaceuticals
AMLX
$3.46B
$3.46B $26.95 3.06%
BHC icon
18
Bausch Health
BHC
$3.11B
$3.11B $8.31 1.31%
XERS icon
19
Xeris Biopharma Holdings
XERS
$3.04B
$3.04B $16.62 0.48%
HCM icon
20
HUTCHMED
HCM
$2.5B
$2.5B $14.37 2.44%
RGC icon
21
Regencell Bioscience
RGC
$2.31B
$2.31B $4.66 1.27%
PBH icon
22
Prestige Consumer Healthcare
PBH
$2.27B
$2.27B $47.90 0.21%
PRGO icon
23
Perrigo
PRGO
$2.26B
$2.26B $16.27 0.56%
BCRX icon
24
BioCryst Pharmaceuticals
BCRX
$1.91B
$1.91B $7.43 0.27%
ETON icon
25
Eton Pharmaceutcials
ETON
$1.81B
$1.81B $62.66 1.91%

Drug Manufacturers - Specialty & Generic Stocks at a Glance

Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.

There are 79 Drug Manufacturers - Specialty & Generic industry stocks tracked by Wall St. Rank, worth a combined $369B.

The largest by market cap are Takeda Pharmaceutical (TAK) at $69.1B, Teva Pharmaceutical Industries (TEVA) at $49B and Haleon (HLN) at $40.1B.

Among institutional investors, Eton Pharmaceutcials (ETON) drew the most net new fund positions in Q3 2026: 76 funds opened new positions, taking total fund holders up 49 (30%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q3 2026.